|
|
|
| |
 |
|
Organisational changes strengthen technical services |
| |
| |
Pharmaterials Ltd, one of the UK’s leading providers of advanced drug development services today announced a new organisational structure to further strengthen the company’s Technical Services offering.
The new Technical Services team has been extended to include three further Technical Specialists. Dr David Churchley will transfer to the position of Head of Solid-Form R&D, having previously supported clients’ needs within the Project Management team. Mridul Majumder will manage the Physical Properties group whilst Dr Chris Kirby will continue in his role of Director of Formulation Development.
Professor Graham Buckton said, “In line with our ongoing commitment to periodically review our business structure, we are strengthening and raising the profile of our Technical Services offering, which will ultimately significantly enhance our ability to deliver a quality service to our Clients. Pharmaterials is a rapidly growing international company and our strategy of becoming a leading provider of outsourced specialised drug development services is already well underway. Our enhanced technical services team will be instrumental to our continued growth within the pharmaceutical and biotech industries.”
Pharmaterials Ltd is a leading provider of outsourced pharmaceutical development services to the international healthcare industry. The company’s core business expertise includes a fully comprehensive product development service, which consists of Solid-state R&D services, Polymorph and salt screening, amorphous content screening anf formulation development for poorly soluble/permeable drugs. |
|
| |
|
|
|
|
|
|
